U.S. FDA panel to discuss lung cancer drug tested only in China

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

Register now for FREE unlimited access to Reuters.com

Feb 10 (Reuters) – A panel of expert advisers to the U.S. Food and Drug Administration will meet on Thursday to discuss whether a lung cancer therapy that has been studied only in China…

Continue Reading


News Source: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-discuss-lung-cancer-drug-tested-only-china-2022-02-10/

Leave a comment